Year: 2014
Type: review
Abstract: During development, hematopoiesis and neovascularization are closely linked to each other via a common bipotent stem cell called the hemangioblast that gives rise to both hematopoietic cells and endothelial cells. In postnatal life, this functional connection between the vasculature and hematopoiesis is maintained by a subset of hematopoietic progenitor cells endowed with the capacity to differentiate into potent proangiogenic cells. These proangiogenic hematopoietic progenitors comprise a specific subset of bone marrow (BM)-derived cells that homes to sites of neovascularization and possess potent paracrine angiogenic activity. There is emerging evidence that this subpopulation of hematopoietic progenitors plays a critical role in vascular health and disease. Their angiogenic activity is distinct from putative "endothelial progenitor cells" that become structural cells of the endothelium by differentiation into endothelial cells. Proangiogenic hematopoietic progenitor cell research requires multidisciplinary expertise in flow cytometry, hematology, and vascular biology. This review provides a comprehensive overview of proangiogenic hematopoietic progenitor cell biology and flow cytometric methods to detect these cells in the peripheral blood circulation and BM.
Source: Cytometry Part A
DOI: 10.1002/cyto.a.22596
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: American Heart Association, American Thoracic Society, Cleveland Clinic, Case Comprehensive Cancer Center, Case Western Reserve University, International Society for Advancement of Cytometry, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Center for Research Resources
Awards: Asthma Inflammation Research, G1541289742, Pulmonary Vascular-Right Ventricular Axis Research Program, G3282213642, G350671700, Pathobiology of Asthma, Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*, Nitric Oxide in Pulmonary Hypertension, Nitric Oxide in Pulmonary Hypertension, Pulmonary Hypertension Breakthrough Initiative, G8375511425, GENERAL CLINICAL RESEARCH CENTER, G9000012298, G9000059275, G9000176715, G9000195290, Case Comprehensive Cancer Center Support Grant
OpenAlex ID: W2117714267
